Vitalhub (TSE:VHI – Free Report) had its target price reduced by Raymond James Financial from C$15.00 to C$11.00 in a report published on Tuesday,BayStreet.CA reports. Raymond James Financial currently has an outperform rating on the stock.
VHI has been the topic of a number of other reports. ATB Cormark Capital Markets cut their target price on shares of Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a report on Tuesday, March 10th. Royal Bank Of Canada decreased their price target on shares of Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating for the company in a research note on Monday, January 26th. Finally, Scotiabank lowered their price objective on shares of Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 4th. One analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company. According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of C$13.86.
Check Out Our Latest Report on VHI
Vitalhub Stock Performance
Vitalhub (TSE:VHI – Get Free Report) last released its quarterly earnings results on Wednesday, March 18th. The company reported C$0.06 EPS for the quarter. The company had revenue of C$31.39 million for the quarter. Vitalhub had a return on equity of 2.75% and a net margin of 5.61%. As a group, analysts forecast that Vitalhub will post 0.2296467 earnings per share for the current year.
Vitalhub Company Profile
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Featured Articles
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
